Alliar Announced 4Q16 Results

Thursday, March 23, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

SÃO PAULO, March 22, 2016 /PRNewswire/ -- Centro de Imagem Diagnósticos S.A. ("Alliar" or "Company") (BM&FBOVESPA: AALR3), the country's third largest

diagnostic company, announces today its results for the fourth quarter of 2016 (4Q16) and full year of 2016.

Highlights:

  • Net Revenue growth of 36% in 2016;
  • Adjusted pro forma EBITDA reached
    R$207.5 million
    in 2016 (22.5% margin, an 81 bps increase);
  • Recurring net income of R$53.7 million in the year versus a net loss of R$19.1 million in 2015; R$39.7 million excluding minority interest;
  • Recurring operating cash flow of R$150.6 million in 2016, versus R$ 112.5 million in the previous year (+ 34%), resulting in a cash conversion of 74%;
  • 19.9% ROIC without goodwill, an increase of 243 bps;
  • Initial public offering (IPO) at BM&F Bovespa, totaling R$ 268 million in net proceeds for the Company and reducing the Net Debt/EBITDA ratio from 2.7x in 2015 to 1.7x, in addition to providing the necessary funds for the expansion plan;
  • Acquisitions of Delfin (leader in diagnostic imaging in the Northeast region of Brazil) and Multilab (one of the main clinical analysis brands of Campo Grande – MS);
  • Addition of 27 PSC (3 mega, 15 standard and 9 collection points), being 9 in the quarter (mega unit CDB Ana Rosa, CDB Perdizes and Multilab units);
  • 18 new MRI machines (+ 18%), with a 9% increase in the average revenue per equipment;
  • 68 new clinical analysis collection rooms (+ 42%); service now available in 35% of the PSCs;
  • 3.3 million patient visits, a 19% increase;
  • Additional ONA-3 accreditation (ONA-3 is the sector's highest quality certification, and is the internal reference for SIGA – Alliar's internal quality program);

For Further Information: ir.alliar.com

CONTACT

INVESTOR RELATIONS TEAM

Carlos Araujo | IROJoaquim Silva| IR Manager Tel.: +5511 5088-1050 E-mail: [email protected] 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/alliar-announced-4q16-results-300428292.html

SOURCE Alliar



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store